A patent review on the development of human cytochrome P450 inhibitors

Author： Francis Sheena   Delgoda Rupika  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.6, 2014-06, pp. : 699-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 16, Iss. 21, 2009-07 ,pp. : 2661-2805

Bentham Science Publishers

Access to resources Recommend Favorite

Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 16, Iss. 27, 2009-09 ,pp. : 3480-3675

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 in the Brain ; A Review

By  

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 245-263

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-01 ,pp. : 310-322

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Flavone Propargyl Ethers as Potent and Selective Inhibitors of Cytochrome P450 Enzymes 1A1 and 1A2

By  

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 275-284

Bentham Science Publishers

Access to resources Recommend Favorite